<Summary id="CDR0000258032" LegacyPDQID="2606" ReplacementFor="CDR0000062801"><SummaryMetaData><SummaryType>Screening</SummaryType><SummaryAudience>Patients</SummaryAudience><SummaryLanguage>English</SummaryLanguage><SummaryDescription>Prostate cancer screening may help detect prostate cancer, but remains controversial as it has not been shown to reduce deaths from prostate cancer. Learn more about prostate cancer screening, including the potential benefits and harms, in this expert-reviewed summary.</SummaryDescription><SummaryURL xref="https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq">Prostate Cancer (PDQ®): Screening</SummaryURL><SummaryToggleURL xref="https://www.cancer.gov/types/prostate/hp/prostate-screening-pdq">Prostate Cancer (PDQ®): Screening</SummaryToggleURL><SummaryEditorialBoard ref="CDR0000028536">PDQ Screening and Prevention Editorial Board</SummaryEditorialBoard><MainTopics><TermRef ref="CDR0000038782">prostate cancer</TermRef></MainTopics><MainTopics><TermRef ref="CDR0000038613">disease screening</TermRef></MainTopics><SummaryAbstract><Para id="_90">This PDQ cancer information summary has current information about prostate cancer screening. It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para><Para id="_91">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Date Last Modified") is the date of the most recent change. The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the PDQ Screening and Prevention Editorial Board.</Para></SummaryAbstract><SummaryKeyWords><SummaryKeyWord>disease screening</SummaryKeyWord><SummaryKeyWord>prostate cancer</SummaryKeyWord></SummaryKeyWords></SummaryMetaData><SummaryTitle>Prostate Cancer Screening (PDQ®)–Patient Version</SummaryTitle><AltTitle TitleType="Browser">Prostate Cancer Screening</AltTitle><AltTitle TitleType="CancerTypeHomePage">Prostate Cancer Screening</AltTitle><SummarySection id="_1"><Title>What Is Screening?</Title><Para id="_2"><GlossaryTermRef href="CDR0000046171" dictionary="Cancer.gov" audience="Patient">Screening</GlossaryTermRef> is  looking for <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> before a person has any <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef>. This can help find
		cancer at an early <GlossaryTermRef href="CDR0000045885" dictionary="Cancer.gov" audience="Patient">stage</GlossaryTermRef>. When <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef> or cancer is found early, it may
		be easier to treat. By the time symptoms  appear, cancer may have begun
		to spread.</Para><Para id="_3"><GlossaryTermRef href="CDR0000044724" dictionary="Cancer.gov" audience="Patient">Scientists</GlossaryTermRef>  are trying to better understand which
		people are more likely to get certain types of cancer. They also study the things
		we do and the things around us to see if they cause  cancer. This
		information helps doctors recommend who should be screened for cancer, which
		screening tests should be used, and how often the tests should be done.</Para><Para id="_4">It is important to remember that your doctor does  not necessarily
		think you have cancer if he or she suggests a  screening test. Screening
		tests are given when you  have no cancer symptoms. Screening tests may be repeated on a regular basis.</Para><Para id="_54">If a screening test result is abnormal, you may need to have more tests done to find out if you have cancer. These are called <GlossaryTermRef href="CDR0000045959" dictionary="Cancer.gov" audience="Patient">diagnostic tests</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_5"><Title>General Information About Prostate Cancer</Title><SummarySection id="_6"><SectMetaData><SectionType>Cancer description</SectionType><SectionType>Organ description</SectionType></SectMetaData><KeyPoint id="_7">Prostate cancer is a disease in which malignant (cancer) cells
		  form in the tissues of the prostate.</KeyPoint><Para id="_8">The <GlossaryTermRef href="CDR0000046539" dictionary="Cancer.gov" audience="Patient">prostate</GlossaryTermRef> is a
		  <GlossaryTermRef href="CDR0000046386" dictionary="Cancer.gov" audience="Patient">gland</GlossaryTermRef> in the male
		  <GlossaryTermRef href="CDR0000046564" dictionary="Cancer.gov" audience="Patient">reproductive system</GlossaryTermRef>. It lies just
		  below the <GlossaryTermRef href="CDR0000046501" dictionary="Cancer.gov" audience="Patient">bladder</GlossaryTermRef> (the <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organ</GlossaryTermRef> that
		  collects and empties <GlossaryTermRef href="CDR0000046642" dictionary="Cancer.gov" audience="Patient">urine</GlossaryTermRef>) and in
		  front of the <GlossaryTermRef href="CDR0000046555" dictionary="Cancer.gov" audience="Patient">rectum</GlossaryTermRef> (the lower part
		  of the <GlossaryTermRef href="CDR0000046335" dictionary="Cancer.gov" audience="Patient">intestine</GlossaryTermRef>). It is about the
		  size of a walnut and surrounds part of the <GlossaryTermRef href="CDR0000046640" dictionary="Cancer.gov" audience="Patient">urethra</GlossaryTermRef> (the tube that empties urine from the
		  bladder). The prostate gland makes <GlossaryTermRef href="CDR0000044669" dictionary="Cancer.gov" audience="Patient">fluid</GlossaryTermRef> that is part of the <GlossaryTermRef href="CDR0000046703" dictionary="Cancer.gov" audience="Patient">semen</GlossaryTermRef>.
		  <MediaLink ref="CDR0000450023" type="image/jpeg" alt="Drawing of the male reproductive system and urinary system anatomy showing the front and side views of the ureters, bladder, prostate gland, vas deferens, urethra, penis, and testicles. A side view of the seminal vesicle and ejaculatory duct is also shown. The drawing also shows front and side views of the rectum and lymph nodes in the pelvis." language="en" placement="image-center" id="_77"><Caption language="en">Anatomy of the  male reproductive and urinary systems showing the ureters, bladder, prostate gland, urethra, penis, testicles, and other organs.</Caption></MediaLink></Para><Para id="_9">As men age, the prostate may get bigger. A bigger prostate may  block the
		  flow of urine from the     bladder and cause problems with sexual function.  This <GlossaryTermRef href="CDR0000651193" dictionary="Cancer.gov" audience="Patient">condition</GlossaryTermRef> is called <GlossaryTermRef href="CDR0000046509" dictionary="Cancer.gov" audience="Patient">benign prostatic hyperplasia</GlossaryTermRef> (BPH). BPH is not <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>, but <GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">surgery</GlossaryTermRef> may be
		  needed to correct it. The <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef>
		  of BPH or of other problems in the prostate may be
		  similar to symptoms of <GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">prostate cancer</GlossaryTermRef>. <MediaLink ref="CDR0000462221" type="image/jpeg" alt="Two-panel drawing shows normal male reproductive and urinary anatomy and benign prostatic hyperplasia (BPH). Panel on the left shows the normal prostate and flow of urine from the bladder through the urethra. Panel on the right shows an enlarged prostate pressing on the bladder and urethra, blocking the flow of urine." language="en" placement="image-center" id="_78"><Caption language="en">Normal prostate and benign prostatic hyperplasia (BPH). A normal prostate does not block the flow of urine from the bladder. An enlarged prostate  presses on the bladder and urethra and blocks the flow of urine. </Caption></MediaLink></Para><Para id="_87">Other <GlossaryTermRef href="CDR0000044271" dictionary="Cancer.gov" audience="Patient">PDQ</GlossaryTermRef> summaries containing information related to prostate cancer include:</Para><ItemizedList id="_86" Style="bullet"><ListItem><SummaryRef href="CDR0000062853" url="/types/prostate/patient/prostate-prevention-pdq"> Prostate Cancer Prevention</SummaryRef></ListItem><ListItem><SummaryRef href="CDR0000062965" url="/types/prostate/patient/prostate-treatment-pdq">Prostate Cancer Treatment </SummaryRef></ListItem></ItemizedList></SummarySection><SummarySection id="_10"><SectMetaData><SectionType>Incidence</SectionType></SectMetaData><KeyPoint id="_11">Prostate cancer is the most common nonskin cancer among men in
		  the United States.</KeyPoint><Para id="_76">Prostate cancer is most common in older men. In the United States, about one  out of every eight men will be <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosed</GlossaryTermRef> with prostate cancer. Most men diagnosed with this disease do not die from it.    Prostate cancer causes  more deaths in men than any other cancer except <GlossaryTermRef href="CDR0000445043" dictionary="Cancer.gov" audience="Patient">lung cancer</GlossaryTermRef>. Prostate cancer occurs more often in Black men than in White men. Black men with prostate cancer are more likely to die from the disease than White men with prostate cancer.</Para></SummarySection><SummarySection id="_56"><SectMetaData><SectionType>Risk factors</SectionType></SectMetaData><KeyPoint id="_57">Different factors increase or decrease the risk of developing prostate cancer.</KeyPoint><Para id="_58">Anything that increases your chance of getting a disease
		  is called a <GlossaryTermRef href="CDR0000045873" dictionary="Cancer.gov" audience="Patient">risk factor</GlossaryTermRef>. Anything that decreases your chance of getting a disease is called a <GlossaryTermRef href="CDR0000439422" dictionary="Cancer.gov" audience="Patient">protective factor</GlossaryTermRef>.</Para><Para id="_98">To learn more about risk factors and protective factors for prostate cancer, visit <SummaryRef href="CDR0000062853" url="/types/prostate/patient/prostate-prevention-pdq">Prostate Cancer Prevention</SummaryRef>.</Para></SummarySection></SummarySection><SummarySection id="_13"><Title>Prostate Cancer Screening</Title><SummarySection id="_14"><SectMetaData><SectionType>Screening methods</SectionType></SectMetaData><KeyPoint id="_15">Tests are used to screen for different types of cancer when a person does not have symptoms.</KeyPoint><Para id="_59"><GlossaryTermRef href="CDR0000044724" dictionary="Cancer.gov" audience="Patient">Scientists</GlossaryTermRef> study <GlossaryTermRef href="CDR0000046171" dictionary="Cancer.gov" audience="Patient">screening</GlossaryTermRef> tests to find those with the fewest harms and most benefits. <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">Cancer</GlossaryTermRef> screening trials also are meant to show whether early detection (finding cancer before it causes <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef>)  helps a person live longer or decreases a person's chance of dying from the disease. For some types of cancer, the chance of <GlossaryTermRef href="CDR0000454708" dictionary="Cancer.gov" audience="Patient">recovery</GlossaryTermRef> is better if the disease is found and treated at an early <GlossaryTermRef href="CDR0000045885" dictionary="Cancer.gov" audience="Patient">stage</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_18"><KeyPoint id="_19">There is no standard or routine screening test for prostate cancer.</KeyPoint><Para id="_99">Although there are no standard or routine screening tests for <GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">prostate cancer</GlossaryTermRef>, the following tests are being used or studied to screen for it:</Para><SummarySection id="_23"><KeyPoint id="_24">Digital rectal exam</KeyPoint><Para id="_25"> <GlossaryTermRef href="CDR0000045668" dictionary="Cancer.gov" audience="Patient">Digital rectal exam</GlossaryTermRef> (DRE) is an exam of the <GlossaryTermRef href="CDR0000046555" dictionary="Cancer.gov" audience="Patient">rectum</GlossaryTermRef>. The doctor or <GlossaryTermRef href="CDR0000269445" dictionary="Cancer.gov" audience="Patient">nurse</GlossaryTermRef> inserts a <GlossaryTermRef href="CDR0000046302" dictionary="Cancer.gov" audience="Patient">lubricated</GlossaryTermRef>, gloved finger into the lower part of the rectum to feel the <GlossaryTermRef href="CDR0000046539" dictionary="Cancer.gov" audience="Patient">prostate</GlossaryTermRef> for lumps or anything else that seems unusual, such as an enlarged prostate.<MediaLink ref="CDR0000457840" type="image/jpeg" alt="Digital rectal exam; drawing shows a side view of the male reproductive anatomy and the urinary anatomy, including the prostate, rectum, and bladder. Also shown is a gloved, lubricated finger inserted into the rectum to feel the rectum, anus, and prostate." language="en" placement="image-center" id="_79"><Caption language="en">Digital rectal exam (DRE). The doctor inserts a gloved, lubricated finger into the rectum and feels the rectum, anus, and prostate (in males) to check for anything abnormal.</Caption></MediaLink></Para></SummarySection><SummarySection id="_26"><KeyPoint id="_27"> Prostate-specific antigen test</KeyPoint><Para id="_52">A <GlossaryTermRef href="CDR0000322878" dictionary="Cancer.gov" audience="Patient">prostate-specific antigen (PSA) test</GlossaryTermRef> is a test that measures the level of <GlossaryTermRef href="CDR0000044867" dictionary="Cancer.gov" audience="Patient">PSA</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000270735" dictionary="Cancer.gov" audience="Patient">blood</GlossaryTermRef>.  PSA is a substance made mostly  by the prostate that may be found in an increased amount in the blood of men who have prostate cancer.  The level of PSA may also be high in men who have an <GlossaryTermRef href="CDR0000045364" dictionary="Cancer.gov" audience="Patient">infection</GlossaryTermRef> or <GlossaryTermRef href="CDR0000044042" dictionary="Cancer.gov" audience="Patient">inflammation</GlossaryTermRef> of the prostate or <GlossaryTermRef href="CDR0000046509" dictionary="Cancer.gov" audience="Patient">benign prostatic hyperplasia</GlossaryTermRef> (BPH; an enlarged, but noncancerous, prostate).</Para><Para id="_92">A PSA test or a DRE may be able to detect prostate cancer at an early stage, but it is not clear whether  early detection and treatment decrease the risk of dying from prostate cancer.</Para><Para id="_93">Studies are being done to find ways to make PSA testing more accurate for early cancer detection.</Para></SummarySection></SummarySection><SummarySection id="_95"><KeyPoint id="_96">A prostate cancer gene 3 (PCA3) RNA test may be used for certain patients.</KeyPoint><Para id="_97">If a man had a high PSA level and a <GlossaryTermRef href="CDR0000045164" dictionary="Cancer.gov" audience="Patient">biopsy</GlossaryTermRef> of the prostate did not show cancer and the PSA level remains high after the biopsy, a <GlossaryTermRef href="CDR0000798759" dictionary="Cancer.gov" audience="Patient">PCA3 RNA test</GlossaryTermRef> may be done. This test measures the amount of PCA3 RNA in the <GlossaryTermRef href="CDR0000046642" dictionary="Cancer.gov" audience="Patient">urine</GlossaryTermRef> after a DRE. If the PCA3 RNA level is higher than normal, another prostate biopsy may be needed to help <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnose</GlossaryTermRef> prostate cancer.</Para></SummarySection><SummarySection id="_100"><KeyPoint id="_101">Screening tests for prostate cancer are being studied in clinical trials.</KeyPoint><Para id="_100_md_95">Information about <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trials</GlossaryTermRef> supported by <GlossaryTermRef href="CDR0000044267" dictionary="Cancer.gov" audience="Patient">NCI</GlossaryTermRef> can be found on NCI’s <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trials search</ExternalRef> webpage. Clinical trials supported by other organizations can be found on the <ExternalRef xref="https://clinicaltrials.gov/">ClinicalTrials.gov</ExternalRef> website.</Para></SummarySection></SummarySection><SummarySection id="_35"><SectMetaData><SectionType>Risks of screening</SectionType></SectMetaData><Title>Risks of Prostate Cancer Screening</Title><SummarySection id="_36"><KeyPoint id="_37">Screening tests have risks.</KeyPoint><Para id="_38">Decisions about <GlossaryTermRef href="CDR0000810044" dictionary="Cancer.gov" audience="Patient">screening tests</GlossaryTermRef> can be difficult. Not all screening tests are helpful, and most have risks. Before having any screening test, you may
		  want to discuss  the test with your doctor.  It is important to know the risks of
		  the test and whether it has been proven to reduce the risk of dying from
		  <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_39"><KeyPoint id="_40">The risks of prostate cancer screening include:</KeyPoint><SummarySection id="_41"><KeyPoint id="_42">Finding prostate cancer that may never  cause symptoms or become life threatening.</KeyPoint><Para id="_64">Screening
			 may not improve your health or help  you live longer if  you have      cancer that has already spread to the area outside of the  <GlossaryTermRef href="CDR0000046539" dictionary="Cancer.gov" audience="Patient">prostate</GlossaryTermRef> or to
			 other places in  your body.</Para><Para id="_71">Some prostate cancers  never  cause <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef>
			 or become life-threatening, but if    found by a screening
			 test,  the cancer may be treated. Finding these cancers is called <GlossaryTermRef href="CDR0000759894" dictionary="Cancer.gov" audience="Patient">overdiagnosis</GlossaryTermRef>.  It is  not known if treatment of these cancers  would help you live longer than if no treatment  were given.</Para><Para id="_94">Treatments for <GlossaryTermRef href="CDR0000445079" dictionary="Cancer.gov" audience="Patient">prostate cancer</GlossaryTermRef>, such as <GlossaryTermRef href="CDR0000046549" dictionary="Cancer.gov" audience="Patient">radical prostatectomy</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">radiation therapy</GlossaryTermRef>, may have long-term <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef> in many men. The most common side effects are <GlossaryTermRef href="CDR0000321372" dictionary="Cancer.gov" audience="Patient">erectile dysfunction</GlossaryTermRef> and <GlossaryTermRef href="CDR0000373944" dictionary="Cancer.gov" audience="Patient">urinary incontinence</GlossaryTermRef>.</Para><Para id="_88">Some studies of patients with newly <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosed</GlossaryTermRef> prostate cancer showed these patients had a higher risk of death from <GlossaryTermRef href="CDR0000044005" dictionary="Cancer.gov" audience="Patient">cardiovascular</GlossaryTermRef> (heart and <GlossaryTermRef href="CDR0000045020" dictionary="Cancer.gov" audience="Patient">blood vessel</GlossaryTermRef>) disease or <GlossaryTermRef href="CDR0000450124" dictionary="Cancer.gov" audience="Patient">suicide</GlossaryTermRef>. The risk was greatest in the first weeks or months after <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosis</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_83"><KeyPoint id="_84">Complications from a follow-up biopsy can occur.</KeyPoint><Para id="_85">If a <GlossaryTermRef href="CDR0000322878" dictionary="Cancer.gov" audience="Patient">PSA test</GlossaryTermRef> is higher than normal, a <GlossaryTermRef href="CDR0000045164" dictionary="Cancer.gov" audience="Patient">biopsy</GlossaryTermRef> of the prostate may be done. <GlossaryTermRef href="CDR0000463706" dictionary="Cancer.gov" audience="Patient">Complications</GlossaryTermRef> from a biopsy of the prostate may include  <GlossaryTermRef href="CDR0000450108" dictionary="Cancer.gov" audience="Patient">fever</GlossaryTermRef>, pain, <GlossaryTermRef href="CDR0000270735" dictionary="Cancer.gov" audience="Patient">blood</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000046642" dictionary="Cancer.gov" audience="Patient">urine</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046703" dictionary="Cancer.gov" audience="Patient">semen</GlossaryTermRef>, and  <GlossaryTermRef href="CDR0000046095" dictionary="Cancer.gov" audience="Patient">urinary tract</GlossaryTermRef> <GlossaryTermRef href="CDR0000045364" dictionary="Cancer.gov" audience="Patient">infection</GlossaryTermRef>. Even if a biopsy shows that a patient does not have prostate cancer, he may worry more about developing prostate cancer in the future.</Para><Para id="_102"><GlossaryTermRef href="CDR0000805156" dictionary="Cancer.gov" audience="Patient">Magnetic resonance imaging (MRI)−guided biopsy</GlossaryTermRef> is being studied in the  <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosis</GlossaryTermRef> of prostate cancer, either in place of, or in addition to, <GlossaryTermRef href="CDR0000689630" dictionary="Cancer.gov" audience="Patient">standard</GlossaryTermRef> prostate <GlossaryTermRef href="CDR0000045798" dictionary="Cancer.gov" audience="Patient">needle biopsy</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_47"><KeyPoint id="_48">False-negative test results can occur.</KeyPoint><Para id="_61">Screening test results may appear to be normal even though prostate cancer is
			 present. A man who receives a <GlossaryTermRef href="CDR0000340928" dictionary="Cancer.gov" audience="Patient">false-negative test result</GlossaryTermRef> (one that
			 shows there is no cancer when there really is) may delay seeking medical care  even if he has symptoms.</Para></SummarySection><SummarySection id="_44"><KeyPoint id="_45">False-positive test results can occur.</KeyPoint><Para id="_62">Screening test results may appear to be <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> even though no
			 cancer is present. A <GlossaryTermRef href="CDR0000340929" dictionary="Cancer.gov" audience="Patient">false-positive test result</GlossaryTermRef> (one that shows there is cancer when there really isn't)   can cause <GlossaryTermRef href="CDR0000430405" dictionary="Cancer.gov" audience="Patient">anxiety</GlossaryTermRef> and is usually followed by more  tests and procedures (such as
			  a biopsy), which also have risks.</Para></SummarySection></SummarySection><SummarySection id="_50"><Para id="_51">Your doctor can advise you about your risk for prostate cancer and your need for screening tests.</Para></SummarySection></SummarySection><SummarySection id="_AboutThis_1"><Title>About This PDQ Summary</Title><SummarySection id="_AboutThis_2"><Title>About PDQ</Title><Para id="_AboutThis_3">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <ExternalRef xref="https://www.cancer.gov/espanol/publicaciones/pdq">Spanish</ExternalRef>.</Para><Para id="_AboutThis_4">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government’s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</Para></SummarySection><SummarySection id="_AboutThis_5"><Title>Purpose of This Summary</Title><Para id="_AboutThis_6">This PDQ cancer information summary has current information about prostate cancer screening.  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para></SummarySection><SummarySection id="_AboutThis_7"><Title>Reviewers and Updates</Title><Para id="_AboutThis_8">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Updated") is the date of the most recent change.
</Para><Para id="_AboutThis_9">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <ExternalRef xref="https://www.cancer.gov/publications/pdq/editorial-boards/screening-prevention">PDQ Screening and Prevention Editorial Board</ExternalRef>.
</Para></SummarySection><SummarySection id="_AboutThis_10"><Title>Clinical Trial Information</Title><Para id="_AboutThis_11">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
</Para><Para id="_AboutThis_12">Clinical trials can be found online at <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI's website</ExternalRef>. For more information, call the <ExternalRef xref="https://www.cancer.gov/contact/contact-center">Cancer Information Service</ExternalRef> (CIS), NCI's contact center, at 1-800-4-CANCER (1-800-422-6237).
</Para></SummarySection><SummarySection id="_AboutThis_13"><Title>Permission to Use This Summary</Title><Para id="_AboutThis_14">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as “NCI’s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].”
</Para><Para id="_AboutThis_15">The best way to cite this PDQ summary is:</Para><Para id="_AboutThis_21">PDQ® Screening and Prevention Editorial Board. PDQ Prostate Cancer Screening. Bethesda, MD: National Cancer Institute. Updated  &lt;MM/DD/YYYY&gt;. Available at: <ExternalRef xref="https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq">https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq</ExternalRef>.  Accessed &lt;MM/DD/YYYY&gt;. [PMID: 26389306]</Para><Para id="_AboutThis_16">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <ExternalRef xref="https://visualsonline.cancer.gov/">Visuals Online</ExternalRef>. Visuals Online is a collection of more than 3,000 scientific images.
</Para></SummarySection><SummarySection id="_AboutThis_17"><Title>Disclaimer</Title><Para id="_AboutThis_18">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <ExternalRef xref="https://www.cancer.gov/about-cancer/managing-care">Managing Cancer Care</ExternalRef> page.</Para></SummarySection><SummarySection id="_AboutThis_19"><Title>Contact Us</Title><Para id="_AboutThis_20">More information about contacting us or receiving help with the Cancer.gov website can be found on our <ExternalRef xref="https://www.cancer.gov/contact">Contact Us for Help</ExternalRef> page. Questions can also be submitted to Cancer.gov through the website’s <ExternalRef xref="https://www.cancer.gov/contact/email-us">E-mail Us</ExternalRef>.</Para></SummarySection></SummarySection><PatientVersionOf ref="CDR0000062755"/><DateLastModified>2024-12-10</DateLastModified></Summary>
